Suit Says Cytodyne Omitted Side Effects From Ephedra-Free Supplement Label
This article was originally published in The Tan Sheet
The New Jersey Attorney General's Office and the state's Division of Consumer Affairs are seeking to enjoin Cytodyne Technologies from making or disseminating further advertisements that contain unsubstantiated claims about its Xenadrine EFX ephedra-free dietary supplement
You may also be interested in...
Cytodyne's failure to adequately warn consumers about potential risks from taking ephedra-containing Xenadrine RFA-1 is the basis for a wrongful-death lawsuit filed by Orioles pitcher Steve Bechler's widow, Kiley Bechler, July 16
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands